CONMED CORPORATION APIC, Share-based Payment Arrangement, Increase for Cost Recognition
CONMED CORPORATION (CNMD) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $5.23 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-29
- CONMED CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $5.23M, a 6.67% increase year-over-year.
- CONMED CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $5.50M, a 60.31% decline year-over-year.
- CONMED CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $4.58M, a 25.12% decline year-over-year.
- CONMED CORPORATION apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $4.90M, a 29.70% decline year-over-year.
- CONMED CORPORATION apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $28.32M, a 10.82% increase from fiscal 2024.
- CONMED CORPORATION apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $25.56M, a 5.36% increase from fiscal 2023.
- CONMED CORPORATION apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $24.26M, a 11.63% increase from fiscal 2022.
- CONMED CORPORATION apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $21.73M, a 33.02% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.23M 10-Q · filed 2026-07-29 | $10.73M derived: sum of 2 quarters · filed 2026-07-29 | ||
| 2026-03-31 | $5.50M 10-Q · filed 2026-07-29 | |||
| 2025-12-31 | $28.32M 10-K · filed 2026-02-17 | |||
| 2025-09-30 | $4.58M 10-Q · filed 2025-11-06 | $9.49M derived: sum of 2 quarters · filed 2026-07-29 | $23.35M derived: sum of 3 quarters · filed 2026-07-29 | |
| 2025-06-30 | $4.90M 10-Q · filed 2026-07-29 | $18.77M derived: sum of 2 quarters · filed 2026-07-29 | ||
| 2025-03-31 | $13.86M 10-Q · filed 2026-07-29 | |||
| 2024-12-31 | $25.56M 10-K · filed 2026-02-17 | |||
| 2024-09-30 | $6.12M 10-Q · filed 2025-11-06 | $13.10M derived: sum of 2 quarters · filed 2025-11-06 | $19.34M derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $6.97M 10-Q · filed 2025-11-06 | $13.21M derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $6.24M 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $24.26M 10-K · filed 2026-02-17 | |||
| 2023-09-30 | $6.19M 10-Q · filed 2024-10-31 | $12.61M derived: sum of 2 quarters · filed 2024-10-31 | $18.33M derived: sum of 3 quarters · filed 2024-10-31 | |
| 2023-06-30 | $6.42M 10-Q · filed 2024-10-31 | $12.15M derived: sum of 2 quarters · filed 2024-10-31 | ||
| 2023-03-31 | $5.73M 10-Q · filed 2024-10-31 | |||
| 2022-12-31 | $21.73M 10-K · filed 2025-02-18 | |||
| 2022-09-30 | $5.75M 10-Q · filed 2023-10-26 | $11.51M derived: sum of 2 quarters · filed 2023-10-26 | $15.97M derived: sum of 3 quarters · filed 2023-10-26 | |
| 2022-06-30 | $5.75M 10-Q · filed 2023-10-26 | $10.22M derived: sum of 2 quarters · filed 2023-10-26 | ||
| 2022-03-31 | $4.46M 10-Q · filed 2023-10-26 | |||
| 2021-12-31 | $16.34M 10-K · filed 2024-02-28 | |||
| 2021-09-30 | $4.33M 10-Q · filed 2022-10-27 | $8.62M derived: sum of 2 quarters · filed 2022-10-27 | $12.00M derived: sum of 3 quarters · filed 2022-10-27 | |
| 2021-06-30 | $4.29M 10-Q · filed 2022-10-27 | $7.68M derived: sum of 2 quarters · filed 2022-10-27 | ||
| 2021-03-31 | $3.39M 10-Q · filed 2022-10-27 | |||
| 2020-12-31 | $13.11M 10-K · filed 2023-02-21 | |||
| 2020-09-30 | $3.53M 10-Q · filed 2021-10-28 | $7.09M derived: sum of 2 quarters · filed 2021-10-28 | $10.12M derived: sum of 3 quarters · filed 2021-10-28 | |
| 2020-06-30 | $3.56M 10-Q · filed 2021-10-28 | $6.59M derived: sum of 2 quarters · filed 2021-10-28 | ||
| 2020-03-31 | $3.03M 10-Q · filed 2021-10-28 | |||
| 2019-12-31 | $11.78M 10-K · filed 2022-02-22 | |||
| 2019-09-30 | $3.01M 10-Q · filed 2020-10-29 | $6.12M derived: sum of 2 quarters · filed 2020-10-29 | $8.82M derived: sum of 3 quarters · filed 2020-10-29 | |
| 2019-06-30 | $3.11M 10-Q · filed 2020-10-29 | $5.81M derived: sum of 2 quarters · filed 2020-10-29 | ||
| 2019-03-31 | $2.70M 10-Q · filed 2020-10-29 | |||
| 2018-12-31 | $10.04M 10-K · filed 2021-02-22 | |||
| 2018-09-30 | $2.51M 10-Q · filed 2019-10-31 | $5.16M derived: sum of 2 quarters · filed 2019-10-31 | $7.46M derived: sum of 3 quarters · filed 2019-10-31 | |
| 2018-06-30 | $2.65M 10-Q · filed 2019-10-31 | $4.95M derived: sum of 2 quarters · filed 2019-10-31 | ||
| 2018-03-31 | $2.30M 10-Q · filed 2019-10-31 | |||
| 2017-12-31 | $8.47M 10-K · filed 2020-02-24 | |||
| 2016-12-31 | $8.38M 10-K · filed 2019-02-25 | |||
| 2015-12-31 | $7.50M 10-K · filed 2018-02-26 | |||
| 2014-12-31 | $9.33M 10-K · filed 2017-02-27 | |||
| 2013-12-31 | $5.59M 10-K · filed 2016-02-23 | |||
| 2012-12-31 | $5.65M 10-K · filed 2015-02-23 | |||
| 2011-12-31 | $5.24M 10-K · filed 2014-02-24 | |||
| 2010-12-31 | $4.22M 10-K · filed 2013-02-25 | |||
| 2009-12-31 | $4.31M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |